OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Metformin influences drug sensitivity in pancreatic cancer cells
Saverio Candido, Stephen L. Abrams, Linda S. Steelman, et al.
Advances in Biological Regulation (2018) Vol. 68, pp. 13-30
Closed Access | Times Cited: 48
Saverio Candido, Stephen L. Abrams, Linda S. Steelman, et al.
Advances in Biological Regulation (2018) Vol. 68, pp. 13-30
Closed Access | Times Cited: 48
Showing 26-50 of 48 citing articles:
The Chemosensitizing Role of Metformin in Anti-Cancer Therapy
Zhimin Tang, Nan Tang, Shanshan Jiang, et al.
Anti-Cancer Agents in Medicinal Chemistry (2020) Vol. 21, Iss. 8, pp. 949-962
Closed Access | Times Cited: 18
Zhimin Tang, Nan Tang, Shanshan Jiang, et al.
Anti-Cancer Agents in Medicinal Chemistry (2020) Vol. 21, Iss. 8, pp. 949-962
Closed Access | Times Cited: 18
Factors predicting survival in patients with locally advanced pancreatic cancer undergoing pancreatectomy with arterial resection
Niccolò Napoli, Emanuele F. Kauffmann, Concetta Cacace, et al.
Updates in Surgery (2020) Vol. 73, Iss. 1, pp. 233-249
Open Access | Times Cited: 17
Niccolò Napoli, Emanuele F. Kauffmann, Concetta Cacace, et al.
Updates in Surgery (2020) Vol. 73, Iss. 1, pp. 233-249
Open Access | Times Cited: 17
Upregulation of Akt/Raptor signaling is associated with rapamycin resistance of breast cancer cells
Yuri Y. Shchegolev, Danila V. Sorokin, Alexander M. Scherbakov, et al.
Chemico-Biological Interactions (2020) Vol. 330, pp. 109243-109243
Closed Access | Times Cited: 16
Yuri Y. Shchegolev, Danila V. Sorokin, Alexander M. Scherbakov, et al.
Chemico-Biological Interactions (2020) Vol. 330, pp. 109243-109243
Closed Access | Times Cited: 16
The Impact of Epithelial–Mesenchymal Transition and Metformin on Pancreatic Cancer Chemoresistance: A Pathway towards Individualized Therapy
Aistė Gulla, Urte Andriusaityte, Gabrielius Zdanys, et al.
Medicina (2022) Vol. 58, Iss. 4, pp. 467-467
Open Access | Times Cited: 9
Aistė Gulla, Urte Andriusaityte, Gabrielius Zdanys, et al.
Medicina (2022) Vol. 58, Iss. 4, pp. 467-467
Open Access | Times Cited: 9
Synergistic cytotoxicity of dual PI3K/mTOR and FLT3 inhibition in FLT3-ITD AML cells
Salihanur Darici, Manuela Zavatti, Luca Braglia, et al.
Advances in Biological Regulation (2021) Vol. 82, pp. 100830-100830
Open Access | Times Cited: 11
Salihanur Darici, Manuela Zavatti, Luca Braglia, et al.
Advances in Biological Regulation (2021) Vol. 82, pp. 100830-100830
Open Access | Times Cited: 11
Effects of the MDM-2 inhibitor Nutlin-3a on PDAC cells containing and lacking WT-TP53 on sensitivity to chemotherapy, signal transduction inhibitors and nutraceuticals
Saverio Candido, Stephen L. Abrams, Linda S. Steelman, et al.
Advances in Biological Regulation (2019) Vol. 72, pp. 22-40
Closed Access | Times Cited: 11
Saverio Candido, Stephen L. Abrams, Linda S. Steelman, et al.
Advances in Biological Regulation (2019) Vol. 72, pp. 22-40
Closed Access | Times Cited: 11
Mechanisms of Action of Metformin
Samira A. Mahmood
IntechOpen eBooks (2021)
Open Access | Times Cited: 10
Samira A. Mahmood
IntechOpen eBooks (2021)
Open Access | Times Cited: 10
Periplocin Induces Apoptosis of Pancreatic Cancer Cells through Autophagy via the AMPK/mTOR Pathway
Hewei Zhang, Yongqiang Wang, Yan Zhang, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-13
Open Access | Times Cited: 7
Hewei Zhang, Yongqiang Wang, Yan Zhang, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-13
Open Access | Times Cited: 7
Abilities of β-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells
Shaw M. Akula, Saverio Candido, Stephen L. Abrams, et al.
Advances in Biological Regulation (2019) Vol. 75, pp. 100672-100672
Closed Access | Times Cited: 10
Shaw M. Akula, Saverio Candido, Stephen L. Abrams, et al.
Advances in Biological Regulation (2019) Vol. 75, pp. 100672-100672
Closed Access | Times Cited: 10
Plasma exosomal miR-122 regulates the efficacy of metformin via AMPK in type 2 diabetes and hepatocellular carcinoma
Hui Peng, Mei Hou, Zixin Wu, et al.
Heliyon (2022) Vol. 8, Iss. 11, pp. e11503-e11503
Open Access | Times Cited: 6
Hui Peng, Mei Hou, Zixin Wu, et al.
Heliyon (2022) Vol. 8, Iss. 11, pp. e11503-e11503
Open Access | Times Cited: 6
Metformin Restores the Drug Sensitivity of MCF-7 Cells Resistant Derivates via the Cooperative Modulation of Growth and Apoptotic-Related Pathways
Danila V. Sorokin, Yuri Y. Shchegolev, Alexander M. Scherbakov, et al.
Pharmaceuticals (2020) Vol. 13, Iss. 9, pp. 206-206
Open Access | Times Cited: 8
Danila V. Sorokin, Yuri Y. Shchegolev, Alexander M. Scherbakov, et al.
Pharmaceuticals (2020) Vol. 13, Iss. 9, pp. 206-206
Open Access | Times Cited: 8
Effects of chloroquine and hydroxychloroquine on the sensitivity of pancreatic cancer cells to targeted therapies
James A. McCubrey, Stephen L. Abrams, Matilde Y. Follo, et al.
Advances in Biological Regulation (2022) Vol. 87, pp. 100917-100917
Open Access | Times Cited: 5
James A. McCubrey, Stephen L. Abrams, Matilde Y. Follo, et al.
Advances in Biological Regulation (2022) Vol. 87, pp. 100917-100917
Open Access | Times Cited: 5
Sensitivity of pancreatic cancer cells to chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals can be regulated by WT-TP53
Stephen L. Abrams, Shaw M. Akula, Alberto M. Martelli, et al.
Advances in Biological Regulation (2021) Vol. 79, pp. 100780-100780
Closed Access | Times Cited: 7
Stephen L. Abrams, Shaw M. Akula, Alberto M. Martelli, et al.
Advances in Biological Regulation (2021) Vol. 79, pp. 100780-100780
Closed Access | Times Cited: 7
Effects of the MDM2 inhibitor Nutlin-3a on sensitivity of pancreatic cancer cells to berberine and modified berberines in the presence and absence of WT-TP53
Stephen L. Abrams, Shaw M. Akula, Linda S. Steelman, et al.
Advances in Biological Regulation (2021) Vol. 83, pp. 100840-100840
Open Access | Times Cited: 7
Stephen L. Abrams, Shaw M. Akula, Linda S. Steelman, et al.
Advances in Biological Regulation (2021) Vol. 83, pp. 100840-100840
Open Access | Times Cited: 7
Integrative Management of Pancreatic Cancer (PDAC): Emerging Complementary Agents and Modalities
M.B.A. Djamgoz, Valerie Jentzsch
Nutrition and Cancer (2021) Vol. 74, Iss. 4, pp. 1139-1162
Open Access | Times Cited: 6
M.B.A. Djamgoz, Valerie Jentzsch
Nutrition and Cancer (2021) Vol. 74, Iss. 4, pp. 1139-1162
Open Access | Times Cited: 6
Pharmacological Modulation of Apoptosis and Autophagy in Pancreatic Cancer Treatment
Johnson Stanslas, Mohammad Kaisarul Islam, Nityaa Selvarajoo, et al.
Mini-Reviews in Medicinal Chemistry (2022) Vol. 22, Iss. 20, pp. 2581-2595
Closed Access | Times Cited: 4
Johnson Stanslas, Mohammad Kaisarul Islam, Nityaa Selvarajoo, et al.
Mini-Reviews in Medicinal Chemistry (2022) Vol. 22, Iss. 20, pp. 2581-2595
Closed Access | Times Cited: 4
P-glycoprotein associated with diabetes mellitus and survival of patients with pancreatic cancer: 8-year follow-up
Nan Hu, Hui Wang, Qing Qian, et al.
Brazilian Journal of Medical and Biological Research (2020) Vol. 53, Iss. 11
Open Access | Times Cited: 5
Nan Hu, Hui Wang, Qing Qian, et al.
Brazilian Journal of Medical and Biological Research (2020) Vol. 53, Iss. 11
Open Access | Times Cited: 5
Islets and pancreatic ductal adenocarcinoma – An opportunity for translational research from the ‘Bench to the Bedside’
Savio George Barreto, Michael Michael, Damien J. Keating
Pancreatology (2020) Vol. 20, Iss. 3, pp. 385-390
Closed Access | Times Cited: 4
Savio George Barreto, Michael Michael, Damien J. Keating
Pancreatology (2020) Vol. 20, Iss. 3, pp. 385-390
Closed Access | Times Cited: 4
TP53 Gene Status can Promote Sensitivity and Resistance to Chemotherapeutic Drugs and Small Molecule Signal Transduction Inhibitors.
James A. McCubrey, Matilde Y. Follo, Stefano Ratti, et al.
Advances in Biological Regulation (2024), pp. 101073-101073
Closed Access
James A. McCubrey, Matilde Y. Follo, Stefano Ratti, et al.
Advances in Biological Regulation (2024), pp. 101073-101073
Closed Access
Exploiting the molecular subtypes and genetic landscape in pancreatic cancer: the quest to find effective drugs
Nnenna Elebo, Ebtesam A. Abdel-Shafy, Stefano Cacciatore, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 1
Nnenna Elebo, Ebtesam A. Abdel-Shafy, Stefano Cacciatore, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 1
Targeting the Metabolic Paradigms in Cancer and Diabetes
Mira Bosso, Dania Haddad, Ashraf Al Madhoun, et al.
(2023)
Open Access | Times Cited: 1
Mira Bosso, Dania Haddad, Ashraf Al Madhoun, et al.
(2023)
Open Access | Times Cited: 1
Metformin and colorectal cancer
GAST覰 AMABLE, E. Martínez-León, MAR虯 E. PICCO, et al.
Biocell (2021) Vol. 46, Iss. 1, pp. 51-59
Open Access | Times Cited: 1
GAST覰 AMABLE, E. Martínez-León, MAR虯 E. PICCO, et al.
Biocell (2021) Vol. 46, Iss. 1, pp. 51-59
Open Access | Times Cited: 1
A Personalized Approach to Pancreatic Ductal Adenocarcinoma and its Application in Surgical Practice
Dimitriοs Schizas, Alkmini Koumpoura, Meropi Galari, et al.
Personalized Medicine (2021) Vol. 18, Iss. 6, pp. 613-627
Closed Access | Times Cited: 1
Dimitriοs Schizas, Alkmini Koumpoura, Meropi Galari, et al.
Personalized Medicine (2021) Vol. 18, Iss. 6, pp. 613-627
Closed Access | Times Cited: 1
